Do you think Novartis don't have the resources to get the products into clinics- those surgeons don't care if the company is Novartis or Mesoblast the treatment is the same and they invested 100 million- plenty of skin in the game now- if this was purely transactional, Novartis hostile TO would be a no brainer. MSB need to up their game and up the SP if they don't want to be acquired- they have great products, treatments- their communication sucks and their Sp is a screaming TO.
Deadline for Novartis, page-198
-
- There are more pages in this discussion • 232 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 19746 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |